Summary
Synopsys Inc. (SNPS) reported solid financial results for the third quarter and first nine months of fiscal year 2016, demonstrating continued revenue growth and robust operational performance. Total revenue increased by 11% year-over-year for the quarter and 8% for the nine-month period, driven by strong performance in time-based license revenue, which constitutes the majority of the company's revenue, as well as growth in upfront license and maintenance/service revenues. The company maintained healthy profitability, with net income increasing by 17% for the quarter. Synopsys also continued to generate significant operating cash flow, leading to an increase in cash, cash equivalents, and short-term investments to over $1 billion. The company's balance sheet remains strong, with effective management of assets and liabilities. Management is confident in the company's liquidity and ability to meet its financial obligations, supported by strong operational cash generation and an undrawn portion of its credit facility.
Financial Highlights
53 data points| Revenue | $615.20M |
| Cost of Revenue | $139.68M |
| Gross Profit | $475.53M |
| R&D Expenses | $221.87M |
| Operating Expenses | $398.81M |
| Operating Income | $76.72M |
| Interest Expense | $1.21M |
| Net Income | $64.72M |
| EPS (Basic) | $0.43 |
| EPS (Diluted) | $0.42 |
| Shares Outstanding (Basic) | 151.17M |
| Shares Outstanding (Diluted) | 153.89M |
Key Highlights
- 1Total revenue increased by 11% to $615.2 million for the third quarter ended July 31, 2016, compared to the prior year period.
- 2Time-based license revenue, the company's largest revenue stream, grew by 8% for both the three and nine-month periods, indicating continued demand for its core offerings.
- 3Net income for the third quarter rose by 17% to $64.7 million, showcasing improved profitability.
- 4Operating cash flow remained strong, with $439.0 million generated for the nine months ended July 31, 2016, an increase of 28% year-over-year.
- 5Cash, cash equivalents, and short-term investments increased by 13% to $1.1 billion, reflecting healthy cash generation and liquidity.
- 6The company successfully managed its debt, with a significant portion of its credit facility remaining undrawn, indicating financial flexibility.
- 7Synopsys is actively engaged in strategic acquisitions, with aggregate consideration of $56.6 million during the nine-month period, contributing to goodwill and intangible assets.